NeoGenomics
210 hedge funds and large institutions have $923M invested in NeoGenomics in 2018 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 72 increasing their positions, 62 reducing their positions, and 14 closing their positions.
15,560% more call options, than puts
Call options by funds: $7.83M | Put options by funds: $50K
307% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 14
26% more funds holding
Funds holding: 167 → 210 (+43)
16% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 62
7.23% less ownership
Funds ownership: 85.6% → 78.36% (-7.2%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
23% less capital invested
Capital invested by funds: $1.2B → $923M (-$278M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Element Capital Management
New York
|
+$33.3M |
| 2 |
LCM
Laurion Capital Management
New York
|
+$18.8M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.9M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$14.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GE
General Electric
Evendale,
Ohio
|
-$230M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$22.2M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$8.77M |
| 4 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
-$7.51M |
| 5 |
Morgan Stanley
New York
|
-$6.13M |
NEO Hedge Fund Activity: Q4 2018 in Review
210 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2018, worth a combined $923M — down 23% from $1.2B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new NEO positions and 14 closed out — a net gain of 43 holders — while 72 added to existing stakes and 62 trimmed.
The largest buyer was Element Capital Management, opening a new position worth an estimated $33.3M. The largest seller was General Electric, exiting entirely with an estimated $230M sold.
- 210 institutional investors held NeoGenomics (NEO) as of Q4 2018, up from 167 in Q3 2018.
- Funds reported $923M of NeoGenomics stock for Q4 2018, down 23% quarter-over-quarter.
- 57 funds opened new NeoGenomics positions in Q4 2018 and 14 closed out, a net change of +43 holders.
- The largest NeoGenomics buyer in Q4 2018 was Element Capital Management, an estimated $33.3M added.
- The largest NeoGenomics seller in Q4 2018 was General Electric, an estimated $230M sold.
Based on aggregated 13F filings for Q4 2018.